The US Food and Drug Administration adviser recommends purchasing Truvada as a way to prevent HIV infection among healthy individuals with an increased threat of contracting the virus that causes AIDS.

“I don’t see it as a panacea, but it is an option, and it is important,” said Dr. Kenneth Mayer, an AIDS specialist and director of medical research at The Fenway Institute at Fenway Health in Boston. “Some people won’t use a condom, but will say, ‘if you give me another choice, I’ll use it.'”

Overcoming barriers to PrEP

Mayer explains, “A person who has not been infected but is exposed to HIV, this drug can prevent the virus from reproducing even if it has invaded cells. As a result, the virus cannot start turning the body of a newly exposed person into a ‘factory’ to produce more HIV particles.”

“Why would you take this drug if you intended to use a condom?” asked the group’s president, Michael Weinstein, in an interview with Bloomberg News. He uses a sartorial metaphor to describe how unlikely it is: “You have to be really paranoid about your pants falling down to wear belts and suspenders.”

David Paltiel, a professor at Yale University School of Medicine, said his research had shown that the use of preventive drug treatments should reduce the overall risk of infection. However, he said, “it is not known whether people (will) take more opportunities because they feel protected by ‘chemical condoms.” However, prevention is better than cure with generic Truvada.

“The potential market for Truvada as a preventative drug includes gay men who have sex with more than one man and committed partners where one person is HIV positive, including multiple heterosexual couples who want to have children,” Mayer said.

Mayer adds, “Enabling marketing might lead to increased use of it for prevention. But, this is not a one-time, end-to-problem approach like penicillin injections to treat infections like syphilis. Also, it involves someone who understands he or she is at risk, or a provider comfortable enough to ask questions. about someone’s risk. We know that many healthcare providers don’t like talking to their patients about sex. ”

Paltiel said, “My research came to the same conclusion: That the wide use of the drug in people at high risk would be” just as cost-effective as public health and other widely accepted medical interventions. “Thus, Canadian pharmacies will support drugs. approved for community welfare.

Harm reduction for HIV prevention

Human immunodeficiency virus (HIV) is a lentivirus (member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancer to develop. HIV infection occurs with the transfer of blood, semen, vaginal fluids, pre-ejaculation, or breast milk. In these body fluids, HIV is present as free viral particles and viruses in infected immune cells. The four main routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (perinatal transmission). Screening of blood products for HIV has largely eliminated transmission through transfusions of blood or infected blood products in developed countries.